Logo image of SBNOR.OL

SPAREBANKEN NORGE (SBNOR.OL) Stock Fundamental Analysis

OSL:SBNOR - Euronext Oslo - NO0006000900 - Common Stock - Currency: NOK

153.58  -1.46 (-0.94%)

Fundamental Rating

3

SBNOR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 92 industry peers in the Banks industry. SBNOR has a bad profitability rating. Also its financial health evaluation is rather negative. SBNOR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SBNOR had positive earnings in the past year.
SBNOR had a positive operating cash flow in the past year.
In the past 5 years SBNOR has always been profitable.
Each year in the past 5 years SBNOR had a positive operating cash flow.
SBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFSBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

SBNOR has a Return On Assets of 0.56%. This is comparable to the rest of the industry: SBNOR outperforms 42.39% of its industry peers.
SBNOR has a worse Return On Equity (7.67%) than 60.87% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 7.67%
ROIC N/A
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
SBNOR.OL Yearly ROA, ROE, ROICSBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

Looking at the Profit Margin, with a value of 23.17%, SBNOR is in line with its industry, outperforming 58.70% of the companies in the same industry.
SBNOR's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for SBNOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.17%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.58%
PM growth 5Y16.69%
GM growth 3YN/A
GM growth 5YN/A
SBNOR.OL Yearly Profit, Operating, Gross MarginsSBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

SBNOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SBNOR has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SBNOR has more shares outstanding
The debt/assets ratio for SBNOR is higher compared to a year ago.
SBNOR.OL Yearly Shares OutstandingSBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SBNOR.OL Yearly Total Debt VS Total AssetsSBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

The Debt to FCF ratio of SBNOR is 41.53, which is on the high side as it means it would take SBNOR, 41.53 years of fcf income to pay off all of its debts.
SBNOR's Debt to FCF ratio of 41.53 is fine compared to the rest of the industry. SBNOR outperforms 77.17% of its industry peers.
A Debt/Equity ratio of 7.02 is on the high side and indicates that SBNOR has dependencies on debt financing.
SBNOR's Debt to Equity ratio of 7.02 is on the low side compared to the rest of the industry. SBNOR is outperformed by 90.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.02
Debt/FCF 41.53
Altman-Z N/A
ROIC/WACCN/A
WACC5.61%
SBNOR.OL Yearly LT Debt VS Equity VS FCFSBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBNOR.OL Yearly Current Assets VS Current LiabilitesSBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

SBNOR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.47%, which is quite impressive.
SBNOR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.42% yearly.
The Revenue has decreased by -3.93% in the past year.
SBNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.96% yearly.
EPS 1Y (TTM)21.47%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%8.64%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%8.77%

3.2 Future

Based on estimates for the next years, SBNOR will show a decrease in Earnings Per Share. The EPS will decrease by -1.12% on average per year.
Based on estimates for the next years, SBNOR will show a quite strong growth in Revenue. The Revenue will grow by 18.89% on average per year.
EPS Next Y-10.04%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
EPS Next 5YN/A
Revenue Next Year44.04%
Revenue Next 2Y27.62%
Revenue Next 3Y18.89%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBNOR.OL Yearly Revenue VS EstimatesSBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
SBNOR.OL Yearly EPS VS EstimatesSBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.02, the valuation of SBNOR can be described as very reasonable.
SBNOR's Price/Earnings is on the same level as the industry average.
SBNOR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.20.
The Price/Forward Earnings ratio is 10.37, which indicates a very decent valuation of SBNOR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBNOR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of SBNOR to the average of the S&P500 Index (22.13), we can say SBNOR is valued rather cheaply.
Industry RankSector Rank
PE 9.02
Fwd PE 10.37
SBNOR.OL Price Earnings VS Forward Price EarningsSBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SBNOR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SBNOR is cheaper than 82.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.1
EV/EBITDA N/A
SBNOR.OL Per share dataSBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.43%, SBNOR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.03, SBNOR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, SBNOR pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.43%

5.2 History

The dividend of SBNOR is nicely growing with an annual growth rate of 41.95%!
Dividend Growth(5Y)41.95%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

112.96% of the earnings are spent on dividend by SBNOR. This is not a sustainable payout ratio.
SBNOR's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP112.96%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
SBNOR.OL Yearly Income VS Free CF VS DividendSBNOR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
SBNOR.OL Dividend Payout.SBNOR.OL Dividend Payout, showing the Payout Ratio.SBNOR.OL Dividend Payout.PayoutRetained Earnings

SPAREBANKEN NORGE

OSL:SBNOR (5/28/2025, 7:00:00 PM)

153.58

-1.46 (-0.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners31.58%
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner ChangeN/A
Market Cap26.05B
Analysts81.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.43%
Yearly Dividend24.3
Dividend Growth(5Y)41.95%
DP112.96%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.88%
Min EPS beat(2)-3.55%
Max EPS beat(2)5.31%
EPS beat(4)3
Avg EPS beat(4)5.86%
Min EPS beat(4)-3.55%
Max EPS beat(4)14.66%
EPS beat(8)6
Avg EPS beat(8)4.43%
EPS beat(12)8
Avg EPS beat(12)12.21%
EPS beat(16)12
Avg EPS beat(16)13.75%
Revenue beat(2)0
Avg Revenue beat(2)-7.09%
Min Revenue beat(2)-13.13%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-13.13%
Max Revenue beat(4)8.42%
Revenue beat(8)6
Avg Revenue beat(8)16.3%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.02
Fwd PE 10.37
P/S 3.12
P/FCF 6.1
P/OCF 6.01
P/B 1.03
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)17.03
EY11.09%
EPS(NY)14.81
Fwd EY9.64%
FCF(TTM)25.16
FCFY16.38%
OCF(TTM)25.55
OCFY16.63%
SpS49.26
BVpS148.81
TBVpS145.55
PEG (NY)N/A
PEG (5Y)0.52
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 7.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.17%
GM N/A
FCFM 51.08%
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.58%
PM growth 5Y16.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 7.02
Debt/FCF 41.53
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 220.46%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.57%
Profit Quality(3y)228.56%
Profit Quality(5y)217.4%
High Growth Momentum
Growth
EPS 1Y (TTM)21.47%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%8.64%
EPS Next Y-10.04%
EPS Next 2Y-5.69%
EPS Next 3Y-1.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%8.77%
Revenue Next Year44.04%
Revenue Next 2Y27.62%
Revenue Next 3Y18.89%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.85%
FCF growth 3Y28.27%
FCF growth 5Y61.38%
OCF growth 1Y52.46%
OCF growth 3Y27.09%
OCF growth 5Y18.41%